Lewis B, Goldfarb N
The Mount Sinai Medical Center, New York, NY, USA.
Aliment Pharmacol Ther. 2003 May 1;17(9):1085-96. doi: 10.1046/j.1365-2036.2003.01556.x.
Capsule endoscopy is a new, wireless, endoscopic examination of the small intestine. To date, two small clinical trials have been reported utilizing capsule endoscopy in patients with obscure gastrointestinal bleeding, and have shown its superiority to push enteroscopy in diagnosing the cause of blood loss. No outcome studies have been reported. This paper proposes a change in practice guidelines for obscure bleeding. It is our opinion that, in the future, with the advent of wireless capsule endoscopy, the evaluation of patients with obscure gastrointestinal bleeding will be very different from the practice of medicine today. We believe that capsule endoscopy will become the first-line method for the evaluation of patients with obscure bleeding, once upper endoscopy and colonoscopy have been shown to be negative. In patients with active bleeding, capsule endoscopy will confirm the small bowel as the site of bleeding, providing a location, or, if the study is negative for the small intestine, may indicate that the bleeding is either colonic or gastric in origin. In a patient with active bleeding within the small intestine, the capsule will guide further evaluation and therapy. A patient with a small bowel tumour detected by capsule endoscopy will proceed directly to laparoscopic surgery. If the site of bleeding is identified in the proximal small bowel and there is no mass, push enteroscopy will be used to re-identify the site and cauterize it. A distal small bowel site will require surgical intervention, coupled with intra-operative enteroscopy. Should the patient be too sick to undergo surgery, medical therapy utilizing hormonal agents will be considered. A colonic site will be evaluated by colonoscopy. In patients with a more occult or intermittent type of bleeding and in those whose upper endoscopies and colonoscopies are negative, capsule endoscopy will be used similarly to identify a bleeding lesion and thereby direct subsequent testing or treatment.
胶囊内镜是一种新型的、无线的小肠内镜检查方法。迄今为止,已有两项小型临床试验报道了在不明原因胃肠道出血患者中使用胶囊内镜,结果显示其在诊断失血原因方面优于推进式小肠镜检查。目前尚未有关于其疗效的研究报道。本文提议对不明原因出血的实践指南进行修订。我们认为,未来随着无线胶囊内镜的出现,对不明原因胃肠道出血患者的评估将与当今的医疗实践有很大不同。我们相信,一旦上消化道内镜检查和结肠镜检查结果为阴性,胶囊内镜将成为评估不明原因出血患者的一线方法。对于有活动性出血的患者,胶囊内镜将确定小肠为出血部位,提供出血位置;或者,如果小肠检查结果为阴性,则可能表明出血源于结肠或胃。对于小肠内有活动性出血的患者,胶囊内镜将指导进一步的评估和治疗。通过胶囊内镜检测出小肠肿瘤的患者将直接进行腹腔镜手术。如果在近端小肠确定了出血部位且没有肿块,将使用推进式小肠镜重新确定出血部位并进行烧灼止血。远端小肠出血部位则需要手术干预,并在术中进行小肠镜检查。如果患者病情过重无法接受手术,则考虑使用激素药物进行内科治疗。结肠部位将通过结肠镜检查进行评估。对于出血更为隐匿或呈间歇性的患者,以及上消化道内镜检查和结肠镜检查结果为阴性的患者,胶囊内镜的使用方式类似,用于识别出血病变,从而指导后续的检查或治疗。